Receives Import And Market Permission In Form Ct-20 From Drugs Controller General Of India For Olaparib
19/08/2022 13:29
Astrazeneca Pharma India Ltd ASTR.NS :
* ASTRAZENECA PHARMA INDIA LTD - RECEIVES IMPORT AND MARKET
PERMISSION IN FORM CT-20 FROM DRUGS CONTROLLER GENERAL OF INDIA
FOR OLAPARIB
Source text for Eikon: ID:nBSES2wx
Further company coverage: ASTR.NS
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication